Name: Name:2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-
Brand: Angene
SKU: AG001JXC
Rating: 90 (10 reviews)

2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-

CAS No.:

1446502-11-9

Catalog Number:

AG001JXC

Molecular Formula:

C19H17F6N7O

Molecular Weight:

473.3750

Pack Size

Purity

Availability

Location

Price(USD)

Quantity

5mg

≥98%

1 week

United States

$166

- +

10mg

99%

1 week

United States

$223

- +

50mg

99%

1 week

United States

$540

- +

100mg

99%

1 week

United States

$873

- +

Product Description

Catalog Number:

AG001JXC

Chemical Name:

2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-

CAS Number:

1446502-11-9

Molecular Formula:

C19H17F6N7O

Molecular Weight:

473.3750

MDL Number:

MFCD29472245

IUPAC Name:

2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol

InChI:

InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)

InChI Key:

DYLUUSLLRIQKOE-UHFFFAOYSA-N

SMILES:

CC(CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)c1cccc(n1)C(F)(F)F)(O)C

UNII:

3T1SS4E7AG

Properties

Complexity:

635

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

473.14g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

473.383g/mol

Monoisotopic Mass:

473.14g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

109A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

3.5

Literature

Title	Journal
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.	Blood 20170810
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.	Blood 20170810
Isocitrate dehydrogenase mutations in myeloid malignancies.	Leukemia 20170201

Properties